The Centers For Medicare And Medicaid (CMS) Release Billing Guidelines For COVID-19 Vaccine
29.12.2020
•
Posted by Provider Relations
The following codes have been published as of November 10, 2020. However, they will not be billable until the specific vaccine receives official EUA approval. Similar to other COVID-19 services, the vaccines will be offered at no cost to your patients.
Fidelis Care is closely following advancements in the prevention and treatment of COVID-19, including vaccinations. As a healthcare provider, you will play an integral role as COVID-19 vaccines become available. We want to update you on important new information about vaccine coverage.
To prepare for vaccine administration, the Centers for Medicare and Medicaid (CMS) have published billing guidance. The following codes have been published as of November 10, 2020. However, they will not be billable until the specific vaccine receives official EUA approval. Similar to other COVID-19 services, the vaccines will be offered at no cost to your patients
Code
|
CPT Short Descriptor
|
Labeler Name
|
Vaccine/Procedure Name
|
91300
|
SARSCOV2 VAC
30MCG/0.3ML IM
|
Pfizer
|
Pfizer-Biotech Covid-19 Vaccine
|
0001A
|
ADM SARSCOV2 VAC
30MCG/0.3ML 1ST
|
Pfizer
|
Pfizer-Biotech Covid-19 Vaccine
Administration – First Dose
|
0002A
|
ADM SARSCOV2 VAC
30MCG/0.3ML 2ND
|
Pfizer
|
Pfizer-Biotech Covid-19 Vaccine
Administration – Second Dose
|
91301
|
SARSCOV2 VAC
100MCG/0.5ML IM
|
Moderna
|
Moderna Covid-19 Vaccine
|
0011A
|
ADM SARSCOV2 VAC
100MCG/0.5ML 1ST
|
Moderna
|
Moderna Covid-19 Vaccine
Administration – First Dose
|
0012A
|
ADM SARSCOV2 VAC
100MCG/0.5ML 2ND
|
Moderna
|
Moderna Covid-19 Vaccine
Administration – Second Dose
|
Medicaid , Healthier Life, Essential Plan, Qualified Health Plan and Children’s Health Insurance Program (CHIP):
- Fidelis Care will configure its systems to properly adjudicate COVID-19 vaccine-related claims, both for the vaccine and its administration, in accordance with New York’s coverage determinations for Medicaid beneficiaries
- Member liability will be $0
- Non-participating provider pre-authorization requirements will be waived
- Provider reimbursement rates and emergency use authorizations (EUA) are all still pending and we will update you as that information becomes available
Medicare:
- For Calendar Years (CYs) 2020 and 2021, Medicare payment for the COVID-19 vaccine and its administration for Medicare Advantage plan members will be made through the original fee-for-service Medicare program.
- Fidelis Care will not be able to process these claims.
- Therefore, providers must submit claims for administering the COVID-19 vaccine to their CMS Medicare Administrative Contractor (MAC) using product-specific codes for each vaccine approved.
The American Medical Association (AMA) has published updates to the Current Procedural Terminology (CPT®) code set that includes new vaccine-specific codes to report immunizations for the novel coronavirus (SARS-CoV-2). The code set will continue to be updated as additional vaccines receive emergency use authorization (EUA) approval by the U.S. Food & Drug Administration (FDA).
Additionally, CMS has also published a set of toolkits to help providers prepare to swiftly administer the vaccine once it is available. If you have any further questions about this upcoming vaccine or the COVID-19 services Fidelis Care covers, please contact Provider Services at 1-888-FIDELIS (1-888-343-3547).